Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H3N2v Vaccine Safety and Immunogenicity in Healthy Children
NCT02100436Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2014
- Primary completion
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza A/H3N2v vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2014; status: completed.
02
Drugs
influenza A/H3N2v vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02100436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02100436.